Allstate general counsel sells 28,652 shares

Q: How many ALL shares did Christine M. DeBiase sell, and at what prices?

The sales totaled 28,652 shares on November 6, 2026: 21,368 at a weighted average of $261.9070 per share and 7,284 at $261.4201 per share. Actual prices for the 21,368-share sale ranged from $261.760 to $262.210. The transactions were not reported as made under a Rule 10b5-1 plan.

Q: What did the ALL option award footnote say about vesting?

The option award described in the footnote was granted on February 21, 2024, for 10,926 shares of common stock vesting in three equal increments. The remaining increment will vest on February 21, 2027.

The first sale was reported at a weighted average of $261.9070 per share, while the second was reported at $261.4201.

Available on EDGAR 11/10/2026 - 04:07 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:06 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Allstate Corp (ALL) EVP, CLO and General Counsel Christine M. DeBiase exercised options for 21,368 shares at $137.10 and 7,284 shares at $159.17 on November 6, 2026, then sold the corresponding shares at $261.9070 and $261.4201 per share, respectively. The first sale price was a weighted average; actual prices for that sale ranged from $261.760 to $262.210.

Insider Trade Summary

Exercise and Sale: 28,652 shares ($3.41M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider DeBiase Christine M.

Role EVP, CLO and General Counsel

Sold 28,652 shs ($7.50M)

Approx. gross sale proceeds $7.50M

Approx. exercise cost $4.09M

Approx. pre-tax spread $3.41M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	21,368	$0.00	$0.00
Exercise	Employee Stock Option (Right to Buy) ^F2	7,284	$0.00	$0.00
Exercise	Common Stock	21,368	$137.10	$2.93M
Sale	Common Stock ^F1	21,368	$261.907	$5.60M
Exercise	Common Stock	7,284	$159.17	$1.16M
Sale	Common Stock	7,284	$261.4201	$1.90M

Holdings After Transaction: Employee Stock Option (Right to Buy) — 3,642 options (Direct); Common Stock — 12,066.904 shares (Direct)

Footnotes (2)

F1. Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $261.760 to $262.210. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F2. Stock option award granted on February 21, 2024, for 10,926 shares of common stock vesting in three equal increments. The remaining increment will vest on February 21, 2027.

Key Figures

Total shares sold: 28,652 shares Options exercised: 21,368 shares Weighted average sale price: $261.9070 per share +4 more

7 metrics

Total shares sold 28,652 shares November 6, 2026

Options exercised 21,368 shares At $137.10 per share on November 6, 2026

Weighted average sale price $261.9070 per share For the 21,368-share sale on November 6, 2026

Actual sale price range $261.760 to $262.210 per share For the 21,368-share sale

Options exercised 7,284 shares At $159.17 per share on November 6, 2026

Sale price $261.4201 per share For the 7,284-share sale on November 6, 2026

Option award 10,926 shares Granted February 21, 2024; the remaining increment will vest February 21, 2027

Key Terms

Employee Stock Option (Right to Buy), weighted average sale price, vesting, open-market sales transactions

4 terms

Employee Stock Option (Right to Buy) technical

"Employee Stock Option (Right to Buy)"

weighted average sale price financial

"Reflects weighted average sale price for open-market sales transactions"

vesting technical

"vesting in three equal increments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

open-market sales transactions financial

"weighted average sale price for open-market sales transactions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALL shares did Christine M. DeBiase sell, and at what prices?

The sales totaled 28,652 shares on November 6, 2026: 21,368 at a weighted average of $261.9070 per share and 7,284 at $261.4201 per share. Actual prices for the 21,368-share sale ranged from $261.760 to $262.210. The transactions were not reported as made under a Rule 10b5-1 plan.

What did the ALL option award footnote say about vesting?

The option award described in the footnote was granted on February 21, 2024, for 10,926 shares of common stock vesting in three equal increments. The remaining increment will vest on February 21, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeBiase Christine M.

(Last)

(First)

(Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK

ILLINOIS

60062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, CLO and General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/06/2026		M		21,368	A	$137.1	33,434.904	D
Common Stock	11/06/2026		S		21,368	D	$261.907⁽¹⁾	12,066.904	D
Common Stock	11/06/2026		M		7,284	A	$159.17	19,350.904	D
Common Stock	11/06/2026		S		7,284	D	$261.4201	12,066.904	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$137.1	11/06/2026		M			21,368	02/16/2026	02/16/2033	Common Stock	21,368	$0	0	D
Employee Stock Option (Right to Buy)	$159.17	11/06/2026		M			7,284	⁽²⁾	02/21/2034	Common Stock	7,284	$0	3,642	D

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $261.760 to $262.210. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. Stock option award granted on February 21, 2024, for 10,926 shares of common stock vesting in three equal increments. The remaining increment will vest on February 21, 2027.

	/s/ Meghan E. Jauhar, attorney-in-fact for Christine M. DeBiase	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR